(32) showed that CD70, TNFRSF14, and CD58 were the main mutated genes among patients with HBV-associated DLBCL, leading to a decrease in T-cell infusion in the tumor microenvironment and thereby weakening tumor immune surveillance and accelerating their escape. Here, TNFRSF14 is linked to neoplasm.